我现在了解信息，好多是通过豆包和ChatGPT问。
给出的回答感觉还算是合理的。
如果的问个例，那一定要样本多，而且样本的选择，是个很高技术含量的事。
【 在 TeWu 的大作中提到: 】
: 红极一时的华人月子中心，干的也是利用信息差坑蒙拐骗。
--
FROM 120.244.202.*

你说的这个现象，问一下ChatGPT，回答比较满意。有敏感词，发不出来。让ChatGPT转成英文了。
问：美国血制品在全球所占的市场份额很高，这是真的吗？美国的血液的来源是什么？是因为美国M血的人多吗？
答：Yes, the United States holds a significant share of the global blood products market, especially in the field of plasma-derived products. According to market research data, the U.S. accounts for over 60% of the global plasma supply, and in some cases, even more. Several key factors contribute to this phenomenon:

1. Main Source of Plasma: Paid Plasma Donation
The majority of blood products in the U.S. come from paid plasma donations, rather than traditional unpaid blood donations. Unlike many countries that emphasize voluntary, unpaid donations, the U.S. allows and encourages individuals to donate plasma for compensation. This system greatly expands the plasma supply and attracts a large number of regular donors.

High Frequency: Plasma can be donated twice a week, unlike whole blood, which can typically be donated only once every 8 weeks.
Financial Incentive: Donors can receive $30 to $50 per donation, which is appealing to people with lower incomes.
2. Well-Developed Plasma Industry Chain
The U.S. has the most advanced plasma industry chain in the world, covering collection, processing, fractionation, and pharmaceutical manufacturing. Several global leading plasma companies, such as CSL Behring, Grifols, and Octapharma, operate numerous plasma collection centers and production facilities in the U.S.

3. Supportive Policies and Regulations
U.S. laws regarding plasma collection and sales are relatively lenient, allowing for plasma exports. This enables the U.S. to meet domestic demand while also being a major supplier of plasma products globally. In contrast, many countries restrict paid plasma donations or ban plasma exports for ethical or safety reasons, further increasing reliance on U.S. plasma.

4. Global Market Demand
Plasma-derived products, such as immunoglobulins, clotting factors, and albumin, are widely used worldwide to treat conditions like immune deficiencies, bleeding disorders, and severe burns. As global healthcare improves, demand for these products continues to rise, and the U.S. remains the primary supplier.

5. Safety and Technological Advantages
Despite the large volume of plasma collected, the U.S. maintains high safety standards in blood management. Rigorous screening, testing, and virus inactivation processes reduce the risk of disease transmission, enhancing global trust in American plasma products.

Conclusion
The U.S.'s dominance in the global blood products market is primarily due to its paid plasma donation system, a mature industry chain, supportive policies, and strong global demand. It’s not simply because there are "more people selling blood" but rather the result of a combination of systemic, industrial, and market-driven factors.
【 在 TeWu 的大作中提到: 】
: 宏观上统计数据也能看出很多问题
: 比如米帝的血液制品销量规模，能说明有足够多的个体卖血才能撑起这个产业
--
FROM 120.244.202.*

哈哈哈
【 在 TeWu 的大作中提到: 】
: 最后那段强行洗地真有趣
: 4%的人口供应了全世界70%的血液，一下子显得高大上了
--
FROM 120.229.81.*